• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Alessia Cimadamore, Antonio Lopez-Beltran, Marina Scarpelli, and Rodolfo Montironi's Letter to the Editor re: Timothy D. Jones, Liang Cheng. Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups. Eur Urol 2021;79:489-91: Towards Molecular Grading of Urothelial Tumors.

作者信息

Jones Timothy D, Cheng Liang

机构信息

Department of Pathology, Norton Healthcare/CPA Laboratory, Louisville, KY, USA.

Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.

出版信息

Eur Urol. 2021 Jun;79(6):e174-e175. doi: 10.1016/j.eururo.2021.03.027. Epub 2021 Apr 3.

DOI:10.1016/j.eururo.2021.03.027
PMID:33824030
Abstract
摘要

相似文献

1
Reply to Alessia Cimadamore, Antonio Lopez-Beltran, Marina Scarpelli, and Rodolfo Montironi's Letter to the Editor re: Timothy D. Jones, Liang Cheng. Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups. Eur Urol 2021;79:489-91: Towards Molecular Grading of Urothelial Tumors.回复阿莱西娅·奇马达莫尔、安东尼奥·洛佩斯 - 贝尔特兰、玛丽娜·斯卡佩利和罗多尔福·蒙蒂罗尼致编辑的信，信的主题为：蒂莫西·D·琼斯、梁成。膀胱肿瘤的组织学分级：联合使用1973年和2004/2016年世界卫生组织系统可为建立预后风险组提供有价值的信息。《欧洲泌尿外科杂志》2021年；79卷：489 - 491页：迈向尿路上皮肿瘤的分子分级
Eur Urol. 2021 Jun;79(6):e174-e175. doi: 10.1016/j.eururo.2021.03.027. Epub 2021 Apr 3.
2
Reply to Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, and Rodolfo Montironi's Letter to the Editor re: Scott Wilkinson, Huihui Ye, Fatima Karzai, et al. Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.03.009: Focus on Intraductal Carcinoma of the Prostate.回复阿莱西娅·奇马达莫尔、梁成、安东尼奥·洛佩斯 - 贝尔特兰、玛丽娜·斯卡佩利和罗多尔福·蒙蒂罗尼致编辑的信，信的主题为：斯科特·威尔金森、叶慧慧、法蒂玛·卡尔扎伊等人所著的《新生前列腺癌异质性驱动进展及对强化激素治疗的抵抗》。《欧洲泌尿外科杂志》即将发表。https://doi.org/10.1016/j.eururo.2021.03.009：聚焦前列腺导管内癌
Eur Urol. 2021 Sep;80(3):e83-e84. doi: 10.1016/j.eururo.2021.06.002. Epub 2021 Jun 18.
3
Re: Timothy D. Jones, Liang Cheng. Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups. Eur Urol 2021;79:489-91.
Eur Urol. 2021 Jun;79(6):e172-e173. doi: 10.1016/j.eururo.2021.03.020. Epub 2021 Apr 8.
4
Reply to Rodolfo Montironi, Liang Cheng, Marina Scarpelli, Alessia Cimadamore, Francesco Montorsi, and Antonio Lopez-Beltran's Letter to the Editor re: Gillian Vandekerkhove, Werner J. Struss, Matti Annala, et al. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. Eur Urol 2019;75:667-75: How Does Circulating DNA Reach the Blood Stream?
Eur Urol. 2019 Sep;76(3):e73-e74. doi: 10.1016/j.eururo.2019.05.036. Epub 2019 Jun 2.
5
Reply to Jérôme Verine's letter to the editor Re: Rodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng, Marina Scarpelli. Re: Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Eur Urol 2013;63:400-1.对热罗姆·韦里纳致编辑信的回复：关于鲁道夫·蒙蒂罗尼、安东尼奥·洛佩斯 - 贝尔特兰、梁成、玛丽娜·斯卡佩利。关于以临床和病理生物学方面为重点的多房囊性肾细胞癌。《欧洲泌尿外科杂志》2013年；63卷：400 - 401页。 （注：原文中页码范围可能有误，按照逻辑推测应该是400 - 401页，否则文献内容引用就不完整，若实际页码无误，请忽略括号内说明）
Eur Urol. 2013 Jun;63(6):e74-5. doi: 10.1016/j.eururo.2013.02.031. Epub 2013 Feb 28.
6
Reply to Rodolfo Montironi, Marina Scarpelli, Alessia Cimadamore, and Gregor Mikuz's Letter to the Editor re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.017. Focus on Our Personal Recollections and Observations.回复鲁道夫·蒙蒂罗尼、玛丽娜·斯卡尔佩利、阿莱西娅·奇马达莫尔和格雷戈尔·米库兹给编辑的信，内容涉及西奥·范德·夸斯特、弗雷德里克·利德伯格、彼得·C·布莱克等人。国际泌尿病理学会关于尿路上皮癌分级的专家意见。《欧洲泌尿外科聚焦》。即将发表。https://doi.org/10.1016/j.euf.2021.03.017。聚焦我们的个人回忆与观察。
Eur Urol Focus. 2022 May;8(3):885-886. doi: 10.1016/j.euf.2021.04.025. Epub 2021 May 12.
7
Re: Rodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng, Marina Scarpelli. Re: Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Eur Urol 2013;63:400-1.
Eur Urol. 2013 Jun;63(6):e72-3. doi: 10.1016/j.eururo.2013.02.030. Epub 2013 Feb 28.
8
Reply to Alessia Cimadamore, Marina Scarpelli, Liang Cheng, et al's Letter to the Editor, re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/. Eur Urol 2019, 76:871.回复阿莱西娅·奇马达莫尔、玛丽娜·斯卡尔佩利、梁成等人致编辑的信，关于：玛丽亚·基娅拉·西吉诺尔菲、贝尔纳多·罗科对《欧洲泌尿外科学会（EAU）指南：2019年前列腺癌》的明智之言。莫泰特N、范登伯格RCN、布里斯E等人。https://uroweb.org/guideline/prostate-Cancer/。《欧洲泌尿外科杂志》2019年，76:871。
Eur Urol. 2020 May;77(5):e128-e129. doi: 10.1016/j.eururo.2020.02.006. Epub 2020 Feb 14.
9
Reply to Alessia Cimadamore, Liang Cheng, Marina Scarpelli, et al's Letter to the Editor re: Alfonso Gómez de Liaño Lista, Nick van Dijk, Guillermo de Velasco Oria de Rueda, et al. Clinical Outcome After Progressing to Frontline and Second-line Anti-PD-1/PD-L1 in Advanced Urothelial Cancer. Eur Urol 2020;77:269-76. Progression and Hyperprogression Versus Pseudoprogression: Morphologic Documentation.
Eur Urol. 2021 Jan;79(1):e20-e21. doi: 10.1016/j.eururo.2020.10.018. Epub 2020 Nov 3.
10
Re: Rodolfo Montironi, Liang Cheng, Antonio Lopez-Beltran, et al. Original Gleason system versus 2005 ISUP modified Gleason system: the importance of indicating which system is used in the patient's pathology and clinical reports. Eur Urol 2010;58:369-73.
Eur Urol. 2011 Mar;59(3):e5-6; author reply e7-8. doi: 10.1016/j.eururo.2010.11.029. Epub 2010 Dec 1.